The U.S. Meals and Drug Administration is popping its consideration to selective serotonin reuptake inhibitors, a category of antidepressant medication…
Read More
FDA rejects RP1 for superior melanoma, says IGNYTE not a ‘well-controlled’ trial
Add matter to e-mail alerts Obtain an e-mail when new articles are posted on …
Read More
We’re studying about Sarepta conceding to FDA, transplant system
Good morning everybody, it’s Jason Mast, filling in for Ed once more. Right here’s a enjoyable truth about medication, pulled…
Read More
New CDER director at FDA, how rescissions have an effect on well being coverage
You’re studying the online version of D.C. Analysis, STAT’s twice-weekly e-newsletter concerning the politics and coverage of well being and…
Read More
FDA panel weighs dangers, advantages of antidepressants throughout being pregnant
Add matter to electronic mail alerts Obtain an electronic mail when new articles are posted…
Read More
Why was a Huge Pharma bigwig tapped for prime FDA submit?
Well being and Human Companies Secretary Robert F. Kennedy Jr. has been throwing a match over Meals and Drug Administration…
Read MoreFDA names Stanford professor Tidmarsh director of Heart for Drug Analysis and Analysis
Add subject to e mail alerts Obtain an e mail when new articles are posted…
Read MoreSarepta resists FDA over Elevidys, company picks high drug regulator| STAT
Good morning everybody, it’s Jason Mast, filling in for Ed. Right now I’m in Pharmalittle’s New York bureau, sipping a…
Read MoreFDA rejects Genentech’s glofitamab-gxbm for DLBCL, stymied by inadequate proof
Add subject to e-mail alerts Obtain an e-mail when new articles are posted on …
Read More
Sarepta inventory falls on FDA gene remedy Elevidys remark
Douglas Ingram, president and chief govt officer of Sarepta Therapeutics Inc., in the course of the Forbes Healthcare Summit in…
Read More
